Lv720
4980 积分 2022-03-27 加入
Trispecific anti-CD3/BCMA/CD38 antibodies for multiple myeloma: a patent evaluation of US20240132615
15小时前
已完结
Evolution of antisense oligonucleotides: navigating nucleic acid chemistry and delivery challenges
3天前
已完结
RNAi-based therapeutics and tumor targeted delivery in cancer
6天前
已完结
Differences in circulating lymphocyte subpopulations among patients with inflammatory polyps, colorectal adenomas and colorectal cancer
8天前
已完结
Emerging Technologies in Inflammatory Bowel Disease
9天前
已关闭
Mucosal-associated invariant T (MAIT) cells, a new source of universal immune cells for chimeric antigen receptor (CAR)-cell therapy
9天前
已完结
Emerging Technologies in Inflammatory Bowel Disease
9天前
已关闭
Is there a place for engineered immune cell therapies in autoimmune diseases?
9天前
已完结
Overcoming chimeric antigen receptor-T (CAR-T) resistance with checkpoint inhibitors: Existing methods, challenges, clinical success, and future prospects: A comprehensive review
11天前
已完结
CAR-T cell therapy for breast cancer: Current status and future perspective
11天前
已完结
皖公网安备34019202002308
